Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
ALLERGAN INC/UNITED STATES

AGN-OLD

ALLERGAN INC/UNITED STATES

ALLERGAN INC/UNITED STATES historical holders

total: 5

Meritage Group ALLERGAN INC/UNITED STATES transactions over time

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2014 Q3
Held for:
1 quarter
Latest activity:
2014 Q4
Nathaniel Simons has been an institutional investor in ALLERGAN INC/UNITED STATES (AGN-OLD) since 2014 Q3. According to 2026 Q1 report, Nathaniel Simons doesn't hold any shares. The fund/company first acquired AGN-OLD in 2014 Q3, initially purchasing 424,030 shares. Since the initial investment, Meritage Group has made 1 more transaction in this position.

When did Nathaniel Simons exit their AGN-OLD position?

Nathaniel Simons no longer holds ALLERGAN INC/UNITED STATES (AGN-OLD). They sold off their entire position in 2014 Q4, closing out an investment that began in 2014 Q3.

When did Nathaniel Simons first invest in AGN-OLD?

Nathaniel Simons first invested in ALLERGAN INC/UNITED STATES (AGN-OLD) in 2014 Q3 at the reported quarter-end price of $178.19 per share, acquiring 424,030 shares in their initial purchase.

What is Nathaniel Simons's average cost basis for AGN-OLD?

Based on historical transaction data, Nathaniel Simons's estimated cost basis for ALLERGAN INC/UNITED STATES (AGN-OLD) is approximately $178.19 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$178.19
Weighted AVG sell price:
$178.19

AGN-OLD transactions history by Meritage Group

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2014 Q4
0.00%
$178.19
-100% (-424,030)
2014 Q3
2.06%
$178.19
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.